Tekla Healthcare Opportunities Fund Declares Monthly Dividend of $0.11 (THQ)

Share on StockTwits

Tekla Healthcare Opportunities Fund (NYSE:THQ) declared a monthly dividend on Monday, March 11th, Wall Street Journal reports. Investors of record on Wednesday, March 20th will be given a dividend of 0.1125 per share on Friday, March 29th. This represents a $1.35 annualized dividend and a yield of 7.74%. The ex-dividend date is Tuesday, March 19th.

Tekla Healthcare Opportunities Fund has increased its dividend by an average of 2.9% per year over the last three years.

THQ opened at $17.44 on Thursday. Tekla Healthcare Opportunities Fund has a 12 month low of $15.16 and a 12 month high of $18.92.

ILLEGAL ACTIVITY WARNING: “Tekla Healthcare Opportunities Fund Declares Monthly Dividend of $0.11 (THQ)” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this article on another site, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The correct version of this article can be viewed at https://www.tickerreport.com/banking-finance/4220593/tekla-healthcare-opportunities-fund-declares-monthly-dividend-of-0-11-thq.html.

About Tekla Healthcare Opportunities Fund

Tekla Healthcare Opportunities Fund is a closed ended balanced mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating in the healthcare sector. The fund also invests in pooled investment vehicles.

See Also: Why do commodities matter?

Dividend History for Tekla Healthcare Opportunities Fund (NYSE:THQ)

Receive News & Ratings for Tekla Healthcare Opportunities Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tekla Healthcare Opportunities Fund and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Miragen Therapeutics  Given Buy Rating at Wedbush
Miragen Therapeutics Given Buy Rating at Wedbush
Somewhat Positive Media Coverage Extremely Likely to Affect The Coca-Cola  Share Price
Somewhat Positive Media Coverage Extremely Likely to Affect The Coca-Cola Share Price
National CineMedia  Raised to “Buy” at Zacks Investment Research
National CineMedia Raised to “Buy” at Zacks Investment Research
Analyzing RYB Education  & Blue Calypso
Analyzing RYB Education & Blue Calypso
Zendesk Inc  SVP Sells $66,384.48 in Stock
Zendesk Inc SVP Sells $66,384.48 in Stock
Nordson Co.  Stake Lessened by ETF Managers Group LLC
Nordson Co. Stake Lessened by ETF Managers Group LLC


© 2006-2019 Ticker Report